{'fraction_non_alphanumeric': 0.009195402298850575, 'fraction_numerical': 0.0, 'mean_word_length': 5.228571428571429, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Adjuvant therapy with zoledronic Acid and menopausal status.

Zoledronic acid as adjuvant therapy in breast cancer patients has been shown to have a beneficial effect on OS. Adjuvant treatment with clodronate also may improve OS in patients with early breast cancer. Further study with analysis of subgroups by age or menopausal status should be performed to investigate adjuvant therapy with bisphosphonates in breast cancer patients.